News for the Multiple Sclerosis Community

Teriflunomide study recruiting RRMS subjects

This study will assess the safety and effectiveness of an investigational study drug (oral teriflunomide) versus placebo (an inactive substance which contains no active medication) in people ages 18-55 years old with RMS.

Click the link to find out how to enroll.